Medical/Pharmaceuticals

3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

HONG KONG, Aug. 26, 2021 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today unveiled its 2021 interim results. 3SBio maintained strong performance in core businesses, with core products occupying a leading market share. Meanwhile, the Company continuously increased ...

2021-08-26 22:09 5310

Everest Medicines Announces First Person Dosed in Global Phase 3 Registration Trial of Sacituzumab Govitecan-Hziy in China for Metastatic Urothelial Cancer

SHANGHAI, Aug. 26, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-08-26 21:40 4400

Modern Chinese Medicine Announces Year 2021 Interim Results

PERFORMANCE HIGHLIGHTS * Revenue increased by 8.8% to RMB171.8 million * Gross profit increased by 10.4% to RMB78.6 million * Profit after tax increased by 10.5% to approximately RMB44.1 million * The increase in revenue was primarily driven by the surge in revenue generated from the sales...

2021-08-26 20:46 4719

INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NAS...

2021-08-26 20:00 2553

RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results and operational highlights for the second quarter...

2021-08-26 19:56 4853

RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing strong inhibiti...

2021-08-26 19:50 2684

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

HYDERABAD, India, Aug. 26, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that it has become a signatory of the Uni...

2021-08-26 19:19 2354

CStone Pharmaceuticals Announces 2021 Interim Results

SUZHOU, China, Aug. 26, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, today announced 2021 financial results. "In the first...

2021-08-26 19:14 4615

Joint Commission of Taiwan reveals smart dialysis solutions at online forum

TAIPEI, Aug 26, 2021 /PRNewswire/ -- The number of patients with chronic kidney disease inMalaysia is increasing by some 10,000 annually, according to a report from the National Kidney Foundation ofMalaysia (NKF). In order to further promote cooperation betweenTaiwan and Malaysia as it relates to...

2021-08-26 17:33 1876

Elekta's Board announces establishment of philanthropic Elekta Foundation

STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The Elekta Foundation's mission is an important part of Elekta's environmental, social, and governan...

2021-08-26 14:21 3180

Seattle Co Develops Rapid Fingerprinting For Covid-19 Variants

First-Ever Technology Receives NIH Grant to Speed Up Availability of Testing SEATTLE, Aug. 26, 2021 /PRNewswire/ -- ID Genomics (IDG), a Seattle -based company, has invented a dipstick-based, rapid test for simultaneous identification of a large number of genetic variants of SARS-CoV-2 and has jus...

2021-08-26 04:32 1380

XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos

BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...

2021-08-25 22:06 2871

Aqueous Ozone by BES Group Proves Effective in Killing COVID-19

SAN ANTONIO, Aug. 25, 2021 /PRNewswire/ -- Aqueous ozone by BES Group's Multi-Purpose Ozone Bottle and Professional Ozone Spray Bottle has proved effective in killing SARS-CoV-2, the virus that causes COVID-19 in testing by a third-party lab at Nara Medical University inJapan.

2021-08-25 22:00 1866

First patient treated in Clarity's Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial

SYDNEY, Aug. 25, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or the "Company"), an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, is pleased to announce that the first US patient has ...

2021-08-25 21:18 4576

endpoint and THREAD Simplify DCT Operations for Key Stakeholders to Reduce Study Timelines

Integration of data capture and transactions ensures that the site and subject stay together in a unified workflow  SAN FRANCISCO and CARY, N.C., Aug. 25, 2021 /PRNewswire/ -- endpoint Clinical , the leader in global interactive response technology (IRT®) for clinical trials, andTHREAD, a leading...

2021-08-25 21:00 2412

Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint

SAN FRANCISCO and SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-08-25 20:53 4402

Report from the Annual General Meeting 2021 in Elekta

STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A statement from the CEO and P...

2021-08-25 20:50 4192

Tigermed Reports 2021 Interim Results with Strong Financial Growth

HANGZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (stock code: 300347.SZ / 3347.HK), a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, reports its interim results for the six months endedJune 30, 202...

2021-08-25 20:49 5884

ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility

* $20 million investment for a new Mfg & R&D facility * Strategic platform for partnering & CDMO business SEOUL, South Korea, Aug. 25, 2021 /PRNewswire/ -- ExoCoBio Inc., the 4th largest exosome player in the world, announced the initiation of its "Project EGMP", starting with the constructio...

2021-08-25 19:44 1312

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia

SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that it has entered into a licensing agreement with PT Etana Biotechnol...

2021-08-25 19:25 3080
1 ... 345346347348349350351 ... 575